Herpes Simplex News and Research

RSS
Herpes simplex is a viral disease caused by herpes simplex viruses; both herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) cause herpes simplex. Infection with the herpes virus is categorized into one of several distinct disorders based on the site of infection.
StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

PS-targeting antibodies can block HIV virus from entering into certain blood cells

PS-targeting antibodies can block HIV virus from entering into certain blood cells

Peregrine's PS-targeting antibodies block HIV from entry into blood cells

Peregrine's PS-targeting antibodies block HIV from entry into blood cells

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces investment report featuring GenVec

CDC survey finds HSV-2 infection as one of the most common STDs in U.S.

CDC survey finds HSV-2 infection as one of the most common STDs in U.S.

DermaGenoma releases The HerpesDX Genetic Test for Frequent Genital Herpes

DermaGenoma releases The HerpesDX Genetic Test for Frequent Genital Herpes

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

Ichor, Profectus announce agreement for clinical development of DNA vaccine programs

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Acyclovir reduces occurrence of HSV-2 genital ulcers but does not affect HIV transmission

Acyclovir reduces occurrence of HSV-2 genital ulcers but does not affect HIV transmission

HSV-2 can reactivate throughout the genital tract

HSV-2 can reactivate throughout the genital tract

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

Researchers explain how HSV dismantles host's defense systems

Researchers explain how HSV dismantles host's defense systems

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

Heart transplant patients face increased risk for skin cancers

Heart transplant patients face increased risk for skin cancers

Swedish agency approves Medivir's Xerclear for treatment of cold sores

Swedish agency approves Medivir's Xerclear for treatment of cold sores

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.